MTBE Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “MTBE Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Methyl tertiary butyl ether (MTBE) is a colorless, volatile, flammable liquid majorly used as fuel component. MTBE is manufactured by catalytic reaction of isobutylene with methanol. MTBE is used as an octane buster in engines. It is also used as oxygenate to increase oxygen in gasoline. MTBE offers good blending properties and reduces the content of formaldehyde and benzene in gasoline. Additionally, it replaces lead compounds enhancing the anti-knocking properties of the fuel. It is also used as a laboratory reagent to extract compounds. It is also used as solvent to dissolve gallstones. Furhermore, it is used as intermediate for methyl methacrylate.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/mtbe-market.html

MTBE is manufactured by reacting isobutene with methanol in a liquid phase reactor in presence of ion exchange resin. MTBE can further be processed to get isobutylene, which on further processing gives derivates such as methyl methacrylate (MMA), butyl rubber and polyisobutylene. Cost effectiveness and excellent blending octane value are the major advantages of methyl tertiary butyl ether. 

The market for methyl tertiary butyl ether (MTBE) was mainly driven by petrochemical applications. MTBE is majorly consumed as an octane buster and as anti-knocking agent in engines. MTBE is preferred over others due to its lower cost and effectiveness. MBTE finds application as a solvent and forms azeotropes with methanol and water. MBTE has various opportunities as a solvent in various chemicals. However, health and environmental issues related with MTBE can act as a major restraint for the market in upcoming years. Moreover, availability of substitutes also poses as a threat to the growth of the market. Additionally, biofuels mandate in European Union and the U.S. will be major constraint for the market.

In terms of demand, Asia Pacific was the leading region in MBTE market. Growing demand of MBTE from automotive engine market has been the major driver for the growth in the market. India, Japan and China are the major consumers of MTBE in Asia Pacific region. Asia Pacific was followed by North America where the demand for MBTE is anticipated to grow in upcoming years. U.S. and Canada are the leading countries and exhibit higher demand for MTBE in the North American region. Moreover, the demand for MTBE for fuel purpose is declining due to regulations in this region. In addition, there are some ground water concerns regarding MTBE in the U.S. However, the demand for MTBE is likely to grow from more lucrative markets such as Latin America and Europe. Europe is expected to be lucrative market for MTBE in near future. The Rest of the World market is expected to show greater potential for MTBE market in next few years. The Middle East market is likely to exhibit more demand for MTBE in upcoming years due to increased gasoline quality requirements in this region. 

Some of the key manufacturers in the MTBE market are Huntsman Corporation, LyondollBasell Industries, Oxeno Antewerpen, Panjin Hayen Industrial Group, Petroliam Nasional Berhad (Petronas), Saudi Basic Industries Corporation (SABIC), Zhenhai Refining and Chemical and Reliance Industries Ltd. among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of .

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

More Reports On Chemical & Materials Market: - http://www.transparencymarketresearch.com/chemical-market-reports-2.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

Ubiquitin Proteasome Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2013 – 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Ubiquitin Proteasome Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Proteasomes are the protein complexes present inside eukaryotes and a few prokaryotes. Proteolysis is the main function of these proteasomes, in which, unnecessary or damaged proteins are degraded by the breakage of peptide bonds catalyzed by enzymes called as proteases. This overall system of protein degradation is known as ubiquitin proteasome system.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/ubiquitin-proteasome-drugs.html

Ubiquitin proteasome system plays an important role in a variety of basic cellular processes and signaling pathways such as regulation of cell cycle, cell division and differentiation, DNA repair, transcriptional regulation, regulation of the immune responses and modulation of cell surface receptors. The regular degradation of proteins is crucial for maintenance of almost all biological processes including cell proliferation, cell metabolism and apoptosis.

Research in the field of ubiquitin proteasome is expanding exponentially. For instance, intensive research is going on in the field of applications of ubiquitin proteasome system in the treatment of cancer, as the pharmacological inhibition properties of proteasomes can be effective in cancer treatment. Potential sites of therapeutic interventions are also under research and the selective inhibition of disease specific components is also being studied for the purpose of developing treatments for diseases such as neurodegenerative disorders. This indicates a bright future market potential depending upon the time required for commercialization. Currently, there is only one approved ubiquitin proteasome system product available in the market named Velcade. In 2009, total sales of Velcade were estimated to be 1.4 billion and being the only approved drug, its sales are expected to achieve growth at a high compounded annual growth rate.

Although a lot of basic knowledge about the mechanism of ubiquitin proteasome systems is available, its real commercial potential has not yet been fully discovered. The market for ubiquitin proteasome can be divided into four segments on the basis of geography, namely North America, Europe, Asia-Pacific and Rest of the World.

Some of the companies involved in the research and development of ubiquitin proteasome systems are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novelix Pharmaceuticals, Inc., GlaxoSmithKline Pharmaceuticals Ltd. and Onyx Pharmaceuticals, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

Blood Disease Treatment Drugs Market – Global Analysis and Industry Forecast, 2013-2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Sparkling Bottled Water Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Blood comprises of red blood cells, white blood cells, plasma and platelets. Sometimes, people might be affected with different types of blood disorders and blood cancers due to aging, infections, exposure to certain chemicals, smoking, genetic disorders and other factors. 

Browse Full Report with TOC: http://www.transparencymarketresearch.com/blood-disease-treatment-drugs.html

Hence, the category of blood disorders is wide and numerous types of diseases fall under it. There are three main types of cancer that affect blood namely leukemia which affects the bone marrow and is caused by abnormal production of white blood cells. Myeloma is a type of blood cancer that affects plasma cells whereas lymphoma is a cancer that affects the lymphatic system. The diseases that affect white blood cells are mainly lymphoma and leukemia and  anemia, sickle cell anemia and polycythemia diseases are mainly affecting red blood cells. Diseases such as heparin, thrombocytopenia and essential thrombocytosis affect the platelets found in blood and hemophilia and sepsis affect blood plasma. 

Hematological cancers represent a significant problem globally. Every year more than 100,000 cases of blood cancers are diagnosed in United States and more than 50,000 people die from such cancer cases. Many specific therapies for the treatment of cancers have been developed that include biologics and small-molecule drug therapies. Leukemia accounts for the ninth most common occurring cancer in males across the globe. Leukemia market is segmented into four types that include acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Thus, with the rise in number of cancer cases the market in future is projected to grow. 

Drugs such as Sprycel, Arranon, Clolar, Gleevec, Quizartinib, Marqibo, and Tasigna are the major drugs available for the treatment of leukemia. The blood diseases treatment drugs market is witnessing competition among the players with drugs in pipeline for early diagnosis and treatment of blood disorders. 

Some of the key players in the blood disease treatment drugs market include Novartis International AG, Celgene Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals, Ambit Bioscience and other major players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports on Pharmaceutical Market:  http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. 

Contact Us 

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com/ 

Browse Market Research Report:- 

http://www.tmrblog.com/ 

http://marketingfirmblog.wordpress.com/

Global Treatments For Neurodegenerative Disorders Market

Neurodegenerative disorders cause progressive loss of function structure of the neurons in the human brain. The most commonly known neurodegenerative diseases are Alzheimer’s, Parkinson’s, Amyotrophic lateral sclerosis, and Huntington’s Syndrome. Most neurodegenerative disorders are caused because of genetic mutation in completely unrelated cells.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/neurodegenerative-disorders.html

Increase in the awareness regarding mental disorders and the rise in research and development regarding the treatment of such disorders are the major factors that are driving the growth of this market. However, despite large scale advancement in research in this field, there is a lack of complete curative treatment measures due to the manifold nature of the diseases. Moreover, many of the drugs presently available are for the treatment of symptoms of such diseases.

The market for neurodegenerative diseases can be categorized into major segments namely, progressive dementia, dementia with other neurological abnormalities and movement disorders. Out of these segments, the largest market share is occupied by progressive dementia followed by dementia with other neurological abnormalities. The major diseases segmented under neurodegenerative disorders are Huntington’s disease, Alzheimer’s disease, Pick’s disease, corticobasal ganglionic degeneration, Lewy body dementia, progressive supranuclear palsy, Hallervorden-Spatz disease, and multiple system atrophy.

Geographically, this market can be classified as North American, European, Asia Pacific, and the Rest of the World market. The major players in the neurodegenerative disorders market are Abbott Laboratories, Acorda Therapeutics, Inc., Baxter International, Inc., Boehringer Ingelheim Ltd., Cipla Ltd., Cellzome AG, Colucid Pharmaceuticals, Inc., Daiichi Sankyo Co. Ltd., Glenmark Generics Ltd., Neuro-Hitech, Inc., Roche Holding Ltd. and others.

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports On Pharmaceutical Market: -http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

Factor And Growrh Of Continuous Glucose Monitoring(CGM) Market 2013 - 2019

The global continuous glucose monitorin(CGM) market was valued at USD 0.37 billion in 2012 and is expected to grow at a CAGR of 13.6% from 2013 to 2019, to reach an estimated value of USD 0.91 billion in 2019.

Browse Global Sterilization Equipment and Disinfectants Market Report with Full TOC athttp://www.transparencymarketresearch.com/continuous-glucose-monitoring.html

Continuous glucose monitoring systems (CGMS) are real time glucose monitoring devices that measure and display the glucose level of the interstitial fluid in the skin cells of the patient. These devices help patients manage diabetes (Type 1 and Type 2) in a more efficient manner. CGM devices typically comprise a sensor, transmitter and a receiver. The sensor is placed underneath the skin for monitoring glucose levels and is attached to the transmitter that relays the information to the monitor. Until recently, management of diabetes involved the use of conventional blood glucose meters that provided a single time snapshot of the patient's blood glucose level. However, demand for real time monitoring, minimally invasive and effective diabetes management solutions led to the advent of CGM devices. Rise in the incidence of diabetes globally coupled with increasing awareness of such devices that possess the ability to detect hyper and hypoglycemic events in real time will fuel the growth of this market during the forecast period.

CGM is a rapidly evolving market supported by increasing adoption of these systems by hospitals and individual practitioners who further encourage their patients to use these devices. However, CGM systems are not meant to be replaced by the traditional diabetes management devices. Hence, the technology still requires innovation in terms of accuracy and precision. Reimbursement issues, high cost of devices and low market penetration rates are some of the factors that are expected to hinder market growth in the near future. Medtronic's Guardian Real Time CGM System accounted for the largest share of the global marketin 2012, accounting for a share of over 40%. The product's first mover advantage in the market, proper positioning and marketing of the product, and ease of convenience and usability helped it achieve this leadership position. Dexcom's fourth generation product, namely, Dexcom G4 Platinum is anticipated to witness the highest market growth at a CAGR of 22.6% during the forecast period. G4 Platinum is the most recently launched device (2012) and is the most technologically advanced, offering more accuracy and reliability as compared to other commercially available devices. In addition, integration of this device with insulin pumps from various other manufacturers like Johnson & Johnson and Tandem Diabetes Care would also drive the growth of this market segment.

Geographically, North America captured majority share of the global continuous glucose monitoring market in 2012. Increase in type I diabetic population along with rise in geriatric population which will in turn spur the demand for regular monitoring of glucose levels will fuel the growth of this market. Major players of this market are domiciled in this region, which allows easy market penetration and will also contribute towards market growth. The European CGM market is in a rapidly evolving state and contributed the largest share of the total CGM market revenue in 2012. Asia-Pacific is expected to witness tremendous increase its market share and emerge as the fastest growing region, reporting a CAGR of 16.9% during the forecast period. Economic developments, presence of a large patient pool, rising patient awareness, increasing disposable income and changing lifestyle are some of the significant factors that are poised to increase the demand for CGM systems in this region.

Key players in this market include Medtronic, Inc., Dexcom, Inc. and Abbott Diabetes Care. Medtronic was the leading player of this market in 2012, accounting for a share of over 50%. Abbott saw a decline in its market share due to withdrawal of Free Style Navigator from the U.S. market in the fourth quarter of 2011. However, the expected launch of Free Style Navigator ll in 2014 in the U.S. market would help the company restore its market position. Other companies such as Johnson & Johnson, Bayer Healthcare and Tandem Diabetes Care are adopting the strategy of partnerships and collaboration to enter this dynamic market.

The global continuous glucose monitoring market is segmented as follows:

Continuous Glucose Monitoring Market, by Device/Brand

1. Guardian Real Time CGM System


2. Dexcom Seven Plus


3. Dexcom G4 Platinum


4. FreeStyle Navigator


5. MiniMed Paradigm Revel/Veo System


6. Others

BrowseSterilizationEquipmentandDisinfectants Market athttp://www.transparencymarketresearch.com/continuous-glucose-monitoring.html

Continuous Glucose Monitoring Market, by Geography

1. North America


2. Europe


3. Asia-Pacific


4. Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new market report published by Transparency Market Research “ Organ Preservation Solutions Market (By Solutions-Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013   -   2019, “ in 2012, the global organ preservation solutions marketwas valued at USD 0.06 billion and is expected to grow at a CAGR of 16.5% during the forecast period 2013 to 2019 to reach a market value of USD 0.20 billion by 2019.

Browse Organ Preservation Solutions Market Report with Full TOC at  http://www.transparencymarketresearch.com/organ-preservation-solutions.html

Organ preservation solutions help in preserving organs for long when they are not inside the living body,which makes them vulnerable to environment outside the human body.Organs that are removed from the human body are preserved using these solutions for various purposes such as organ transplant proceduresandresearch and development of drugs and biologics. The global market for organ preservation solutionshas been estimated togrowat the rate of 16.5% during the forecast period 2013 to 2019. This growth will be primarily driven by the increasing number of patients who are awaiting organ transplants, since these preservation solutions will enable survival of the organs outside the human body post donation by living or deceased donors. In addition, the rising incidences of organ failure in the patient population owing to changes in lifestyles such as smoking, alcohol and fast foodconsumption, along with rise in geriatric population, especially in developed nations such as U.S. and U.K., will also propel the growth of this market. Likewise, increase in per capita healthcare expenditure and theimprovingreimbursement scenarios for organ transplant procedures in various nations such as U.S., U.K. and India will also support the growth of this market.

This report studiesthe market foreight major solutions for preserving organs, amongst which Viaspan and Custodiol together account for the majority share (over75%) of total market in terms of revenue. During the forecast period 2013 to 2019, the Custodiol market is expected to grow at the highest CAGR of 17.1%. This growth is attributed to its extensive utilization for preserving various organs such as kidney and liver, since it is capable of preserving multiple organs unlike other solutions including Perfadex and HBS solution.

The different techniques utilized to preserve organs are static cold storage (SCS),hypothermic perfusion preservation (HPP) and others. HPP is a machine perfusion technique and maintains continuous supply of the solution needed by organs, unlike SCS that does not allow continuous contact of the organ with the solution.This property increases the survival duration of organs which will in turn augment its demand in the market. The HPP market is expected to grow at a CAGR of 19.2% during the forecast period 2013 to 2019.

The European region accounted for the largest share in terms of revenue of the total global organ preservation solutions market in 2012, and is expected to grow at the highest CAGR of 17.3% during the forecast period 2013 to 2019. This is due to the presence of a large number of organ donors in the region. For instance, in 2011 total number of deceased organ donors in the U.K. was around 1,056 according to the European Commission (EC). Also, the European region exhibited highest rate of aging of population which will also help propel the growth of this market.

The global organ preservation solutions market is ruled by players such as Teva Pharmaceutical Industries Ltd.,Bristol-Myers Squibb, Dr. Franz KöhlerChemie GmbH, XVIVO Perfusion AB andBioLife Solutions, Inc. These companies together accounted for around 90% of the total market revenue in 2012. Some other important players operating in the market include CryoLife, Inc., Lifeline Scientific, Claris Lifesciences Ltd., 21st Century Medicine and BioTime, Inc.

The global organ preservation solutions market has been segmented as below:

Organ Preservation Solutions Market, by Solution 

• Viaspan
• Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
• Renograf
• Hypothermosol
• Perfadex
• Lifor
• Human bioSystem (HBS) Solution
• siRNA Transplant Solutions
• Others

Organ Preservation Solutions Market, by Preservation Technique

• Hypothermic Perfusion Preservation (HPP)
• Static Cold Storage (SCS)
• Others

Organ Preservation Solutions Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Related Report : 

Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/pharmacovigilance-market.html

A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge in number of acute and chronic diseases has consequently led to a rise in number of drug consumption, which has also elicited a growth in the number of adverse drug events and drug toxicity cases. Moreover, several high-profile safety issues, regulatory warnings, large volume of events to be reviewed along with negative media coverage have compelled the pharmaceutical players to take support of various outsourcing services. There are two major outsourcing services opted by these pharmaceutical players i.e. traditional CROs and BPOs. These outsourcing services not only provide cost savings but also helps in bringing process efficiency. Pharmaceutical companies are now forming long term partnership with the CROs and BPOs to share the costs involved in PV process right from drug discovery to post marketing approvals. In addition, PV requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting.

The research report on pharmacovigilance provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of pharmacovigilance market on the bases of clinical trials phases i.e. Phase I to III and post marketing surveillance (PMS). We have also mapped the trend for preference of the pharmaceutical players for in-house and outsourcing in our chapter by type of service.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact us :

Sheela AK

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Life Sciences BPO Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research is Published new Market Report " Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Life Sciences BPO market was valued at USD 152.5 billion in 2012 and is estimated to reach a market value worth USD 596.0 billion in 2019, growing at a CAGR of 21.5% from 2013 to 2019.

Rising cost, growing complexities of conducting clinical trials and increased pressure from regulatory agencies to adopt various techniques to minimize the costs involved for successful introduction of a drug in the market has compelled pharmaceutical players to adopt new outsourcing models. All these factors have helped fuel market growth of the Life Sciences BPO industry in the past decade. In addition, rise in the number of patent expirations and failure of drugs during the clinical trials process has triggered the overall growth of pharmaceutical outsourcing industry. Moreover, outsourcing aids the biotechand pharmaceutical industry to focus on their core strategies and utilize their internal resources for more critical in-house projects.

The Contract Manufacturing Organizations (CMOs) outsourcing services accounts for the largest segment of the overall Life Sciences BPO market. Growing healthcare costs has led to a rise in the demand for generic drugs and this has consequently led to growth in demand for active pharmaceutical outsourcing services. Moreover, CMOs conduct internal R&D to come up with novel technologies to further support their clients. The API manufacturing market accounts to be largest segment of the total CMO market. This growth has been attributed to increase in outsourcing activities for pharmaceutical manufacturing outsourcing, owing to increasing regulatory compliance such cGMP and other approvals. Moreover, manufacturers do not have all the technologies and expertise available in-house required for manufacturing different APIs and hence, outsourcing serves as a more cost effective solution for pharmaceutical companies. Also, the growing importance of biological drugs calls for distinctive manufacturing technology.

The Contract Research Organizations (CROs) outsourcing services market has also witnessed significant growth in the past decade. This growth has been attributed to the rising costs involved in conducting various phases of clinical trials ranging from drug discovery up to post marketing approvals. Pharmaceutical companies are now opting tooutsource their clinical trial activities to vendorscapable of providing bundled services such as regulatory services, clinical data management, medical writing, site management, pharmacovigilance, risk based monitoring, biostatics, protocol development and others. The drug discovery services segment accounted for the largest market share in 2012.Since a large number of molecules fail during the drug discovery process, through outsourcing the pharmaceutical companies are mitigating their financial risks and avoiding sunken costs through partnership with CROs. However, clinical data management outsourcing services market is expected to foresee the highest growth rate of 17.3% from 2013 to 2019. This high growth has been attributed to the growing adoption of advanced IT services such cloud applications and enhanced software services provided by Information Technology Outsourcing (ITO). Data security and Intellectual Property Rights (IPR)still persist to be major hindrance for growth of this industry.

Browse Life Sciences BPO Market Report with Full TOC at http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

Geographically, North America accounted for the largest share of the global pharmaceutical outsourcing services market in 2012 and was valued at USD 28.4 billion in 2012 followed by Asia-Pacific. The Asian-Pacific region is expected to represent the highest growth rate of 21.2% during the forecast period owing to availability of trained resources, low cost labor, favorable regulatory policies and huge patient pool suffering from varies chronic diseases. Moreover, the companies from this region are now meeting the required manufacturing and quality standards of the USFDA and EMEA to further boost market growth.

The major players in this market include Catalent Pharma Solutions, Lonza Group, Parexel International, PRA International, Piramal Healthcare, Charles River Laboratories, PPD (Pharmaceutical Product Development), Cognizant, Accenture, IBM, Quintiles, Covance and others.

Economic burden, increased financial crisis and technological advances has compelled all pharmaceutical, biotechnology and life science companies to outsource their R&D activities and manufacturing processes in order to achieve their cost benefits and save time.In recent years, large number of life science companies has modified their traditional drug manufacturing operationswith more focus now on their core R&D activities and manufacturing processes via outsourcing. At present, new outsourcing strategies and types of services are developing in almost every stage of research and manufacturing process. For instance, a virtually integrated, cross-functional outsourcing of drug discovery research is currently being considered as a latest outsourcing model, especially for small molecule drug discovery. In addition, genomics &proteomics research and gene–silencing technology are now being widely used for target identification and validation of complex disease targets.

Global Life Sciences BPO market includes Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and others that compriseContract Sales Organization (CSO). The contract manufacturing organizations market is expected to see the highest growth rate during the forecast period and also accounted for the largest market share in the year 2012. This market holds immense growth owing to the rise in demand for generic drugs, increase in R&D investment by life sciences companies. In addition, a rise in the number ofblock buster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market. The CMO market comprises contract API (Active Pharmaceutical Ingredients) manufacturing, contract FDF (Finished Dosage Formulations) manufacturing and packaging.Among these, contract FDF manufacturing segment is expected to have a healthy growth rate during the forecast period. The CRO market is also expected to display a healthy growth rate after CMO market. The CRO market comprises of various segments such as drug discovery, pre-clinical studies, clinical trial phases, medical writing, clinical data management, pharmacovigilance, regulatory services, site management, protocol development, monitoring and bio-statistics. 

Among these, clinical data management segment is expected to have a strong growth rate in coming years. This growth has been attributed to its high data complexities, high cost involvement and requirement of skilled & trained professionals.

Geographically, the North American region constituted the largest market for global life sciences BPO market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of over 21.2% from 2013 to 2019. This growth has been attributed to favorable government regulations, improved intellectual property protection rights and increased adoption of novel technologies. In addition, tax benefits, low labor costs andother overheads and availability of skilled professionals at a very low cost compared to developed nations would trigger the growth of this market in Asia-Pacific region.

The major players of this market are CatalentPharma Solutions, PRA International, Covance, Quintiles, Parexel, DSM, Charles River Laboratories, Piramal Healthcare and BoehringerIngelheim.

Related Blog : http://rahul28feb86.wordpress.com/

About US :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Browse all Chemical & Materials Market Research Reports @ http://www.transparencymarketresearch.com/chemical-market-reports-2.html

Contact us :

Sheela AK

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/